Creatinine

Current Opinion in Critical Care

Volumn 16, Issue 6, 2010, Pages 562-567

  Uchino, Shigehiko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

acute kidney injury; acute renal failure; creatinine; cystatin C; neutrophil gelatinaseassociated lipocalin

Indexed keywords

CREATININE; CYSTATIN C; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROCALCITONIN; TROPONIN;

CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DISEASE MARKER; DISEASE SEVERITY; HUMAN; KIDNEY DISEASE; KIDNEY INJURY; OUTCOME ASSESSMENT; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; REVIEW;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; CALCITONIN; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CREATININE; CRITICAL CARE; CYSTATIN C; HUMANS; INTENSIVE CARE UNITS; LIPOCALINS; ORGAN DYSFUNCTION SCORES; POSTOPERATIVE COMPLICATIONS; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS; SENSITIVITY AND SPECIFICITY; TROPONIN;

EID: 78649680785     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e32833ea7f3     Document Type: Review

References (34)

1. Bagshaw S M, Gibney RT. Conventional markers of kidneyfunction. Crit Care Med 2008; 36:S152-S158.
2. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38:1933-1953.
3. Coca S G,Yalavarthy R,Concato J, et al. Biomarkersforthediagnosisand risk stratification of acute kidney injury: a systematic review. Kidney Int 2008; 73:1008-1016.
4. Liebig J. Kreatin und Kreatinin, Bestandtheile des Hams der Menschen [Creatine and creatinine, constituents of the human muscle.]. J Prakt Chem 1847; 40:288-292.
5. Paulmann W. Beitrage zur Kenntniss des Sarkosins [Contributions to the knowledge of sarcosine.]. Arch Pharm 1894; 232:601-639.
6. Colls PC Notes on creatinine. J Physiol 1896; 20:107-111.
7. Rabinowitch IM. The prognostic value of the study of the blood creatinine in nephritis: based upon the study of fourteen cases with complete postmortem examination. Can Med Assoc J 1921; 11:320-322.
8. Rehberg PB.Studieson kidneyfunction: the rateof filtration and reabsorption in the human kidney. Biochem J 1926; 20:447-460.
9. Shannon JA. The renal excretion of creatinine in man. J Clin Invest 1935; 14:403-410.
10. Addis T, Barrett E, Menzies JT. A clinical method for the approximate determination of serum creatinine concentration. J Clin Invest 1947; 26:879-882.
11. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985; 28:830-838.
12. Bellomo R, Ronco C, Kellum JA, et al. Acute Dialysis Quality Initiative work-group. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204-R212.
13. Uchino S, Bellomo R, Goldsmith D, et al. An assessment of the RIFLE criteria foracute renalfailurein hospitalized patients. Crit Care Med 2006; 34:1913-1917.
14. Ricci Z, Cruz D, Ronco C. The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int 2008; 73:538-546.
15. Lassnigg A, Schmidlin D, Mouhieddine M, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a pro-spective cohort study. J Am Soc Nephrol 2004; 15:1597-1605.
16. Mehta R L, Kellum JA, Shah SV, et al.Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31.
17. Uchino S, Bellomo R, Bagshaw SM, et al. Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol Dial Transplant 2010; 25:1833-1839.
18. Devarajan P. Neutrophilgelatinase-associated lipocalin:an emerging troponin for kidney injury. Nephrol Dial Transplant 2008; 23:3737-3743.
19. Cruz DN, deCal M, Garzotto F, et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 2010; 36:444-451.
20. Haase M, Bellomo R, Devarajan P, et al. NGAL Meta-analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 54:1012-1024.
21. Filler G, Bökenkamp A, Hofmann W, et al. Cystatin C as a marker of GFR: history, indications, and future research. Clin Biochem 2005; 38:1-8.
22. Dharnidharka V R, Kwon C, Stevens G. Serum cystatin C is superiorto serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40:221-226.
23. Herget-Rosenthal S, Marggraf G, HüsingJ, et al. Earlydetection ofacute renal failure by serum cystatin C. Kidney Int 2004; 66:1115-1122.
24. Haase-Fielitz A, Bellomo R, Devarajan P, et al. Novel and conventional serumbiomarkers predicting acute kidney injury in adult cardiac surgery: a prpspective cohort study. Crit Care Med 2009; 37:553-560.
25. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Com-mittee for the redefinition of myocardial infarction. Eur Heart J 2000; 21:1502-1513.
26. Reichlin T, Hochholzer W, Bassetti S, et al. Earlydiagnosisof myocardial infarction with sensitive cardiactroponin assays. N Engl J Med 2009;361:858-867.
27. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008; 36:941-952.
28. Schuetz P, Christ-Crain M, Thomann R, et al. Pro HOSP Study Group. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHO S P randomized controlled trial. JAMA 2009; 302:1059-1066.
29. Bouadma L, Luyt CE, Tubach F, et al. PRORATA trial group. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010; 375:463-474.
30. Uzzan B, Cohen R, Nicolas P. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006; 34:1996-2003.
31. Morrow DA, Antman EM, Tanasijevic M, et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. J Am Coll Cardiol 2000; 36:1812-1817.
32. Tang BM, Eslick GD, Craig JC, et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic reviewand meta-analysis. Lancet Infect Dis 2007; 7:210-217.
33. Perianayagam MC, Seabra VF, Tighiouart H, et al. Serum cystatin C for prediction of dialysis requirement or death in acute kidney injury: a comparative study. Am J Kidney Dis 2009; 54:1025-1033.
34. Kleiman NS, Lakkis N, Cannon CP, et al. TACTICS-TIMI 18 Investigators. Prospective analysis ofcreatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes. J Am Coll Cardiol 2002; 40:1044-1050.